Condition: Dry Eye · Sponsor: BioTheraVision, Inc.
This study will be a randomized, vehicle-controlled, double-masked, multiple-dose, parallel-group study to evaluate the efficacy, safety and tolerability of repeat dosing of Cevimeline Ophthalmic Solution compared to the vehicle in subjects with Dry Eye Disease (DED).
This description comes directly from the study's public registry record.
Mulan Lee, PhD · 714.679.8219 · mlee@biotheravision.com
Always discuss trial participation with your own doctor first.
| Cataract and Eye Surgery Centre, Victoria | Doncaster East, Victoria, Australia | Recruiting |
| Sydney Eye Hospital | Sydney, Australia | Recruiting |
| Chang Gung Memorial Hospital-Kaohsiung Branch | Kaohsiung City, Taiwan | Recruiting |
| Kaohsiung Veterans General Hospital | Kaohsiung City, Taiwan | Recruiting |
| Taipei Veterans General Hospital | Taipei, Taiwan | Recruiting |
| Chang Gung Memorial Hospital-LinKou Branch | Taoyuan, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06543303